Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders.

The neuroregulatory activities of PMS-601, a platelet activating factor antagonist, were investigated in laboratory and animal models of HIV-1 encephalitis (HIVE). For the former, PMS-601 reduced monocyte-derived macrophage pro-inflammatory secretions, multinucleated giant cell (MGC) formation, and neuronal loss independent of antiretroviral responses. PMS-601 treatment of HIVE severe combined immunodeficient mice showed reduced microgliosis, MGCs and neurodegeneration. These observations support the further development of PMS-601 as an adjunctive therapy for HIV-1 associated neurocognitive disorders.
AuthorsDawn Eggert, Prasanta K Dash, Nawal Serradji, Chang-Zhi Dong, Pascal Clayette, Francoise Heymans, Huanyu Dou, Santhi Gorantla, Harris A Gelbard, Larisa Poluektova, Howard E Gendelman
JournalJournal of neuroimmunology (J Neuroimmunol) Vol. 213 Issue 1-2 Pg. 47-59 (Aug 18 2009) ISSN: 1872-8421 [Electronic] Netherlands
PMID19541372 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Anti-Inflammatory Agents
  • Immunologic Factors
  • Inflammation Mediators
  • NF-kappa B
  • PMS 601
  • Piperazines
  • Platelet Activating Factor
  • Focal Adhesion Kinase 2
  • Ptk2b protein, mouse
  • AIDS Dementia Complex (drug therapy, immunology, metabolism)
  • Animals
  • Anti-Inflammatory Agents (pharmacology, therapeutic use)
  • Brain (drug effects, metabolism, physiopathology)
  • Cell Death (drug effects, immunology)
  • Cells, Cultured
  • Cognition Disorders (drug therapy, immunology, metabolism)
  • Disease Models, Animal
  • Focal Adhesion Kinase 2 (drug effects, metabolism)
  • Giant Cells (drug effects, immunology, metabolism)
  • Gliosis (drug therapy, immunology, metabolism)
  • Humans
  • Immunologic Factors (pharmacology, therapeutic use)
  • Inflammation Mediators (agonists, metabolism)
  • Male
  • Mice
  • Mice, SCID
  • Microglia (drug effects, immunology, metabolism)
  • Monocytes (drug effects, immunology, metabolism)
  • NF-kappa B (drug effects, metabolism)
  • Piperazines (pharmacology, therapeutic use)
  • Platelet Activating Factor (antagonists & inhibitors, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: